Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56brightCD16− natural killer cells

Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56brightCD16− natural killer cells

Bibliographic Details
Main Authors: Helena Haque Chowdhury, Simon Hawlina, Mateja Gabrijel, Saša Trkov Bobnar, Marko Kreft, Gordan Lenart, Marko Cukjati, Andreja Nataša Kopitar, Nataša Kejžar, Alojz Ihan, Luka Ležaič, Marko Grmek, Andrej Kmetec, Matjaž Jeras, Robert Zorec
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.505

Internet

https://doi.org/10.1002/ctm2.505

Similar Items